People · Operator
Named in public records as an officer, director or promoter · active 2022–2023 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| XOStem Biosciences Ltd. | — | Biotech / Pharma | Pre-Seed | $3.3M | $2.2M | 2022 |
Richard Johns at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Johns on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ALEX MCAULAY | 1 | 9 |
| Gary Yeoman | 1 | 3 |
| BRAD ECKENWEILER | 1 | 3 |
| John Sanderson | 1 | 2 |
| Alex Robert Todd McAulay | 1 | 1 |
| Jonathan Robert Todd Lakey | 1 | 1 |
| Chad Friesen | 1 | 1 |
| Chad Robert Todd Friesen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.